CN1
- Generic Name
- CN1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CN1
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2021-10-18
- Lead Sponsor
- Curon Biopharmaceutical (Australia) Co Pty Ltd
- Target Recruit Count
- 13
- Registration Number
- NCT04418141
- Locations
- 🇦🇹
Mater Medical Centre, Brisbane, Queensland, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath